HS/CN code 30021900 is out of scope for EUDR preparation.
Immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive) The indexed scope engine returns Out of scope for this code. No Annex I scope match was found for this indexed CN code.
Why this reference page gives that answer.
- Code description
- Immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive)
- Annex I basis
- No direct Annex I entry
- Source basis
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Parent, child, and nearby rows.
The library view is for reference navigation. Use the checker when you want to run another code as an action.
30pharmaceutical productsout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300219immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive)out
What this means for preparation.
This row is not a direct evidence-collection trigger in the current scope result.
Regulation (EU) 2023/1115 Annex I — relevant productsretrieved 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115retrieved 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)retrieved 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)retrieved 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8retrieved 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingretrieved 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersretrieved 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)retrieved 2026-08-08